Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: A meta-analysis of cardiovascular outcomes trials
Wang Q et al. Diabetes Res Clin Prac 2018; 143: 34–42. doi: 10.1016/j.diabres.2018.06.009
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.